Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways
- 1 September 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 98, 107780
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Province Postdoctoral Science Foundation (2020Z132)
- National Natural Science Foundation of China (81701805)
- Natural Science Foundation of Jiangsu Province (BK20160193, BK20170201)
This publication has 45 references indexed in Scilit:
- IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in miceJournal of Allergy and Clinical Immunology, 2014
- Growth Inhibitory, Bactericidal, and Morphostructural Effects of Dehydrocostus Lactone from Magnolia sieboldii Leaves on Antibiotic-Susceptible and -Resistant Strains of Helicobacter pyloriPLOS ONE, 2014
- Evidence-based treatment strategies in idiopathic pulmonary fibrosisEuropean Respiratory Review, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- IL-33 Enhances Lipopolysaccharide-Induced Inflammatory Cytokine Production from Mouse Macrophages by Regulating Lipopolysaccharide Receptor ComplexThe Journal of Immunology, 2009
- Molecular Targets in Pulmonary FibrosisChest, 2007
- MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosisThe Journal of Pathology, 2002